DMAA Supplement Direct Seller Ceases Operations Under Consent Decree
This article was originally published in The Rose Sheet
Executive Summary
DoJ filed enters consent decree with VivaCeuticals that forces the California firm to cease marketing its RegeneSlim appetite control product, which was found to contain the stimulant DMAA, and because it violated GMP regulations.
You may also be interested in...
FDA Targets Riddhi GMP Failures: Health And Wellness Industry News In Brief
Complaint filed to shut down Riddhi USA; GOED introduces guidelines to assist industry in preventing oxidation of EPA/DHA oils; UK says B-Life breached ad codes by claiming its ADrop water ionizer can improve health, specifically diabetes; and more health and wellness news in brief.
Regeneca Reaches Recall: Health And Wellness Industry News Roundup
Closed VivaCeuticals business recalls products; Nutrition 21 extends Glanbia distribution agreement; and more news in brief.
DMAA Direct Seller Shut Down: Health And Wellness Industry News Roundup
ViviCeuticals closed in consent decree; Khan moves to top at NCNPR; and more news in brief.